These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31400469)

  • 1. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
    Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
    Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii.
    Çağlan E; Nigiz Ş; Sancak B; Gür D
    Acta Microbiol Immunol Hung; 2020 Jun; 67(2):107-111. PubMed ID: 31813259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
    Germ J; Poirel L; Kisek TC; Spik VC; Seme K; Premru MM; Zupanc TL; Nordmann P; Pirs M
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2159-2162. PubMed ID: 31372908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
    Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
    J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
    Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
    J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two types of colistin heteroresistance in
    Hong YK; Kim H; Ko KS
    Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
    Jo J; Kwon KT; Ko KS
    J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
    Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital.
    Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A
    World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.